IFI16 and neoplasm: Importantly, the re-expression of IFI16 orthologs in immunocompetent mice abrogates tumorigenesis and activates anti-tumor immunity, indicating that early epigenetic changes may influence tumorigenesis by targeting co-located genes (Figure 4, left panels) (136).